Funding is available from NHMRC to support health and medical research, from basic science through to clinical, public health and health services research

NHMRC

 

National Health and Medical Research Council (NHMRC)

The National Health and Medical Research Council (NHMRC) is Australia’s peak body for supporting health and medical research; for developing health advice for the Australian community, health professionals and governments; and for providing advice on ethical behaviour in health care and in the conduct of health and medical research.

 

Background

As at Feb 2014, the 2013 National Health and Medical Research Council (NHMRC) Grant Application Round has resulted in the commitment of more than $800 million to fund health and medical research including 1137 new grants to universities, medical research institutions and hospitals across Australia.

 

Research Areas

Grants to Create New Knowledge

The National Health and Medical Research Council (NHMRC) grants focus on providing funding to support the research undertaken to promote the health of all Australians through the creation of knowledge.

 

Grants to Accelerate Research Translation

NHMRC’s translational schemes fund high quality researchers to conduct the research needed to support the production of scholarly evidence to inform policy and/or practice and the intellectual work to better deal with complex translation pathways.

 

Grants to Build Australia’s Future Capability

To build Australia’s future capability for research and translation, National Health and Medical Research Council funds the best and brightest researchers and research teams and provides infrastructure support grants to support the infrastructure required to complete health and medical research in Australia.

 

Work With Partners

National Health and Medical Research Council (NHMRC) Partnerships for Better Health aims to improve the availability and quality of research evidence to decision makers who design policy and to inform the policy process by supporting more effective connections between the decision makers and the researchers.

 

Media Release

The Turnbull Government will invest $2 million in new medical research to help find a cure for rare genetic epilepsy disorders.

I am pleased to make this announcement on Purple Day, a day dedicated to raising awareness about the impact of epilepsy.

Epilepsy is a chronic disorder of the brain that affects people of all ages, with around 250,000 Australians living with the condition.

This new funding will support our leading researchers to investigate genetic and other causes of epilepsy including the mutation of the Syngap gene, a rare neurological condition which can lead to epilepsy.

The SYNGAP-1 project will be the first project undertaken by the Australian Epilepsy Research Fund, and will be led by researchers from the respected Florey Institute of Neuroscience and Mental Health.

The Australian Epilepsy Research Fund has been established by the Epilepsy Foundation to provide Australians living with genetic and other types of epilepsy hope for the future through medical research.

The Epilepsy Foundation works with individuals and families, organisations and the community to increase people’s understanding of epilepsy.

I want to thank the Epilepsy Foundation for their tireless commitment in supporting people living with epilepsy and their families, and for their work to establish a medical research fund to fight epilepsy.

It is my hope that this funding contributes to a medical breakthrough that will improve the lives of people living with this condition.

Since 2013 the Coalition Government has invested more than $58 million for epilepsy research through the National Health and Medical Research Council (NHMRC).

The Turnbull Government spent more than $71 million on the PBS for medicines to treat epilepsy in 2016-17.

All Australians benefit from the investment in health and medical research.

 

List of National Health and Medical Research Council (NHMRC) grant recipients

RecipientProject
Grant
Prof Philip HansbroElucidating the role and potential for therapeutic targeting of TLR7 in emphysema and COPD
$925,780
Prof Philip HansbroDefining the roles and targeting interferon-epsilon as a new therapy for influenza in asthma and COPD
$905,904
Dr Chantal DonovanTargeting remodelling in chronic obstructive pulmonary disease (COPD), chronic asthma and idiopathic pulmonary fibrosis (IPF)
$386,634
Prof Amanda BakerQuitlink: Accessible smoking cessation support for people living with severe and enduring mental illness
$1,141,189
A/Pr Frederick WalkerMicroglial paralysis in post-stroke neurodegeneration: help or hindrance?
$512,351
A/Pr Frederick WalkerStroke induced disturbances in glymphatic clearance: implications for brain repair?
$491,688
Dr Heather LeeTargeting cancer-initiating cells with DNA methyltransferase inhibitors: single-cell analysis to decipher molecular mechanisms and improve efficacy.
$175,000
A/Pr Brett GrahamExcitatory interneurons: a sensory amplifier for pathological pain
$649,848
A/Pr Christopher GraingeHow does bronchoconstriction worsen asthma?
$1,064,746
Dr Kirsty PringleMaternal Recognition of Fetal Sex in the Regulation of Labour
$455,821
Dr Gerard KaikoFunctional characterisation of novel me